Premium
Aquestive Therapeutics Inc (AQST)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Daniel BarberCEO, President & Director | -8,26k | 35,41k | Vente | 4,29 | 660,57k | -1,23% |
| 2026-05-15 | Dr. Melina T. CioffiSVP of Regulatory Affairs | -1,67k | 6,95k | Sale to Issuer | 4,17 | 273,20k | -0,61% |
| 2026-05-07 | Ms. Lori J. BraenderCorporate Secretary | -135,69k | 573,97k | Sale to Issuer | 4,23 | 231,04k | -37,00% |
| 2026-05-05 | Mr. Peter E. BoydSVP of Information Technology & CPO | -56,78k | 237,33k | Sale to Issuer | 4,18 | 281,73k | -16,77% |
| 2026-05-05 | Mr. Daniel BarberCEO, President & Director | -335,92k | 1,40M | Sale to Issuer | 4,18 | 668,83k | -33,43% |
| 2026-05-05 | Mr. A. Ernest TothSenior VP & CFO | -92,65k | 387,29k | Sale to Issuer | 4,18 | 283,46k | -24,63% |
| 2026-05-05 | Ms. Cassie JungCOO | -72,73k | 304,03k | Sale to Issuer | 4,18 | 204,25k | -26,26% |
| 2026-05-05 | Ms. Lori J. BraenderCorporate Secretary | -76,15k | 318,29k | Sale to Issuer | 4,18 | 366,73k | -17,19% |
| 2026-03-10 | Mr. Daniel BarberCEO, President & Director | -180,68k | 753,97k | Vente | 4,17 | 1,00M | -15,24% |
| 2026-03-10 | Mr. Peter E. BoydSVP of Information Technology & CPO | -29,81k | 124,41k | Vente | 4,17 | 338,51k | -8,09% |
| 2026-03-10 | Mr. A. Ernest TothSenior VP & CFO | -58,25k | 243,09k | Vente | 4,17 | 376,11k | -13,41% |
| 2026-03-10 | Ms. Lori J. BraenderCorporate Secretary | -40,10k | 167,35k | Vente | 4,17 | 442,88k | -8,30% |
| 2026-03-10 | Dr. Melina T. CioffiSVP of Regulatory Affairs | -25,31k | 105,62k | Vente | 4,17 | 128,92k | -16,41% |
| 2026-03-10 | Ms. Cassie JungCOO | -45,79k | 191,09k | Vente | 4,17 | 276,98k | -14,19% |
| 2026-03-10 | Ms. Sherry KorczynskiChief Commercial Officer | -15,74k | 65,69k | Vente | 4,17 | 241,12k | -6,13% |
| 2025-12-02 | Dr. Melina T. CioffiSVP of Regulatory Affairs | -2,08k | 12,35k | Sale to Issuer | 5,93 | 54,23k | -3,70% |
| 2025-10-15 | Ms. Cassie JungCOO | -25,00k | 97,68k | Derivative Exercise and Sale | 3,10 - 7,01 | 242,77k | - |
| 2025-10-15 | Ms. Cassie JungCOO | -42,58k | 298,45k | Automatic Disposition | 7,01 | 242,77k | -14,92% |
| 2025-10-15 | Mr. Peter E. BoydSVP of Information Technology & CPO | -10,00k | 70,00k | Automatic Disposition | 7,00 | 268,32k | -3,59% |
| 2025-10-15 | Dr. Carl N. KrausInitié | -20,27k | 141,90k | Automatic Disposition | 7,00 | 282,48k | -6,70% |
| 2025-09-26 | Mr. Peter E. BoydSVP of Information Technology & CPO | -10,00k | 63,00k | Automatic Disposition | 6,30 | 278,32k | -3,47% |
| 2025-09-26 | Mr. Daniel BarberCEO, President & Director | -91,34k | 551,19k | Automatic Disposition | 6,03 | 923,43k | -9,00% |
| 2025-09-19 | Mr. Daniel BarberCEO, President & Director | -400,00 | 2,40k | Automatic Disposition | 6,00 | 1,01M | -0,04% |
| 2025-09-04 | Ms. Cassie JungCOO | -50,00k | 153,59k | Derivative Exercise and Sale | 0,71 - 5,00 | 285,35k | - |
| 2025-09-04 | Ms. Cassie JungCOO | -12,18k | 60,90k | Automatic Disposition | 5,00 | 285,35k | -4,09% |
| 2025-09-05 | Mr. Peter E. BoydSVP of Information Technology & CPO | -15,00k | 79,50k | Automatic Disposition | 5,30 | 288,32k | -4,95% |
| 2025-08-09 | Dr. Carl N. KrausInitié | -10,82k | 42,19k | Sale to Issuer | 3,90 | 302,75k | -3,45% |
| 2025-06-09 | Ms. Sherry KorczynskiChief Commercial Officer | -2,71k | 9,61k | Sale to Issuer | 3,54 | 156,86k | -1,70% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
